Article
Biochemistry & Molecular Biology
Juliane Strietz, Stella S. Stepputtis, Marie Follo, Peter Bronsert, Elmar Stickeler, Jochen Maurer
Summary: Primary breast cancer stem cell (BCSC) cultures isolated from TNBC specimens have been established and shown to grow as tumor spheres under anchorage-independent culture conditions in vitro, while reliably forming tumors in mice when transplanted in limiting dilutions in vivo. Additionally, these BCSC xenograft tumors exhibit similar architecture and gene expression to the original patient tumor, suggesting a promising model for researching BCSC biology and testing new treatment options for TNBC.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Chemistry, Multidisciplinary
Gokhan Bahcecioglu, Xiaoshan Yue, Erin Howe, Ian Guldner, M. Sharon Stack, Harikrishna Nakshatri, Siyuan Zhang, Pinar Zorlutuna
Summary: The study reveals that aging ECM can drive normal mammary epithelial cells to a more invasive and cancer-like phenotype, and enhance motility and invasiveness in breast cancer cells. Different responses of cells to young and aged ECMs may lead to the identification of new targets for cancer treatment and prevention.
Review
Oncology
Manuel Scimeca, Donata Trivigno, Rita Bonfiglio, Sara Ciuffa, Nicoletta Urbano, Orazio Schillaci, Elena Bonanno
Summary: This review highlights the latest aspects of breast cancer metastasis into the bone, including biomarkers, biological processes related to the origin of metastatic cells, the role of Breast Osteoblast-Like Cells, and the prognostic value of breast microcalcifications for bone metastatic disease. Additionally, the use of molecular imaging investigations for identifying early neoplastic lesions with high propensity to form bone metastasis in vivo is proposed.
SEMINARS IN CANCER BIOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Wenli Zhou, Zhennan Yun, Ting Wang, Chao Li, Jiantao Zhang
Summary: The study reveals the critical roles of BTF3 and BMI1 in colorectal cancer, influencing the stem cell-like traits and epithelial-mesenchymal transition of CRC cells to promote or inhibit metastasis.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
(2021)
Review
Multidisciplinary Sciences
Chuhan Wang, Danli Ma, Huimin Yu, Zhihong Zhuo, Zhiying Ye
Summary: The emergence of drug resistance is a major obstacle in curative cancer treatment. Exploring the molecular mechanisms behind drug resistance, particularly the role of N6-Methyladenosine (m6A) RNA modification, is crucial. Recent evidence has shown that m6A is associated with cancer pathogenesis and drug resistance, impacting cancer stem cell self-renewal, tumor epithelial-mesenchymal transition (EMT), and metastasis. This review provides an overview of the relationship between m6A modulation and drug resistance, discussing the underlying mechanisms and its regulation in EMT and cancer stem cells. Targeting m6A-related proteins to address drug resistance in cancer patients offers significant therapeutic strategies.
Article
Biochemistry & Molecular Biology
Lei Na, Zhuo Wang, Yu Bai, Yu Sun, Dan Dong, Wei Wang, Chenghai Zhao
Summary: This study identified that WNT7B is downregulated in high-grade bladder urothelial carcinomas, and its low expression is associated with poor prognosis. WNT7B inhibits bladder urothelial carcinoma progression by suppressing EMT, stem-like properties, and chemoresistance.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
(2022)
Review
Oncology
Barbora Kvokackova, Jan Remsik, Mohit Kumar Jolly, Karel Soucek
Summary: Epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) play critical roles in the development of TNBC, shaping aggressive and heterogeneous biological features, but may also contribute to the progression of metastatic disease.
Article
Biochemistry & Molecular Biology
Rodrigo A. Acuna, Manuel Varas-Godoy, Diego Herrera-Sepulveda, Mauricio A. Retamal
Summary: Connexins are a family of proteins that play a crucial role in cellular communication, but certain types may have pro-tumorigenic effects. Research has shown that Cx46 can modulate the characteristics of cancer stem cells and epithelial-to-mesenchymal transition in breast cancer cells, potentially influencing future cancer therapies.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Multidisciplinary Sciences
Shaoqiu Zheng, Jing Luo, Shoucheng Xie, Shanming Lu, Qinghua Liu, Huanqin Xiao, Wenjuan Luo, Yanfang Huang, Kun Liu
Summary: Recent evidence suggests that cancer stem cells (CSCs) are the origin of cancers. This study investigated the relationship between tumor buds, which are hypothesized to represent epithelial-mesenchymal transition (EMT)-like CSCs, and EMT and CSC markers in cervical squamous cell carcinoma (CxSCC). The findings indicate that tumor buds in CxSCC may represent EMT-like CSCs in vivo.
Review
Oncology
Xiaobo Zheng, Fuzhen Dai, Lei Feng, Hong Zou, Li Feng, Mingqing Xu
Summary: The interplay between epithelial-mesenchymal plasticity and cancer stem cells plays a crucial role in cancer progression, affecting the aggressiveness of tumor cells and their response to treatment. Understanding the dynamic nature of EMT as a hybrid state rather than a binary model is important for unraveling the complexities of cancer biology and developing targeted therapeutic interventions.
FRONTIERS IN ONCOLOGY
(2021)
Article
Cell Biology
Cihui Yan, Jingjing Chang, Xinmiao Song, Ying Qi, Zhenyu Ji, Ting Liu, Wenwen Yu, Feng Wei, Lili Yang, Xiubao Ren
Summary: The study revealed that MSCs from lung cancer promoted tumor metastasis and tumorigenesis by inducing partial EMT and upregulating stem cell-related genes in lung cancer cells. These findings suggest that LC-MSCs may serve as potential targets or vehicles for lung cancer therapy.
Article
Biochemistry & Molecular Biology
Deguang Kong, Hengbo Zhou, Deepika Neelakantan, Connor J. Hughes, Jessica Y. Hsu, Ramakrishnan Rajaram Srinivasan, Michael T. Lewis, Heide L. Ford
Summary: VEGF-C secreted by EMT breast cancer cells can promote proliferation, migration, and invasion of epithelial breast cancer cells through non-canonical activation of GLI signaling. Inhibiting VEGF-C in EMT cells or knocking down NRP2 in neighboring epithelial cancer cells disrupts the aggressive phenotypes induced by EMT cells, suggesting a novel therapeutic target for metastasis in breast cancer.
Article
Oncology
Olivia McGinn, Duncan Riley, Jessica Finlay-Schultz, Kiran V. Paul, Peter Kabos, Carol A. Sartorius
Summary: Silencing of CK5 and CK17 in basal-like breast cancer cells induces epithelial-mesenchymal transition, leading to a more spindle-like morphology and increased invasiveness in vitro. However, in vivo, CK5 or CK17 knockdown reduces lymph node and lung metastases while enhancing the efficacy of doxorubicin.
MOLECULAR CANCER RESEARCH
(2022)
Article
Cell & Tissue Engineering
Dongli Li, Junxiu Zhang, Zijia Liu, Yuanyuan Gong, Zhi Zheng
Summary: This study revealed that exosomal miR-27b derived from hucMSCs could reverse the EMT process induced by TGF-beta 2 by inhibiting HOXC6, suggesting the potential therapeutic role of the exosomal miR-27b/HOXC6 axis in ameliorating subretinal fibrosis.
STEM CELL RESEARCH & THERAPY
(2021)
Article
Pharmacology & Pharmacy
Jun-Nian Zhou, Tzu-Chen Rautio, Chang Liu, Xiao-Yu Xu, Dong-Qing Wang, Yong Guo, John Eriksson, Hongbo Zhang
Summary: In this study, we successfully delivered PKA to breast cancer cells using the CRISPRMAX reagent, demonstrating its potential to inhibit EMT, affect mammosphere size, and impact chemoresistance. Direct enzyme delivery may be a promising strategy for inhibiting EMT/CSC-associated traits.
Article
Biochemistry & Molecular Biology
Lenora Ann Pluchino, Amethyst Kar-Yin Liu, Hwa-Chain Robert Wang
FREE RADICAL BIOLOGY AND MEDICINE
(2015)
Review
Microbiology
Jun-Da Zhu, Wen Meng, Xiao-Jia Wang, Hwa-Chain R. Wang
FRONTIERS IN MICROBIOLOGY
(2015)
Article
Oncology
Lenora Ann Pluchino, Shambhunath Choudhary, Hwa-Chain Robert Wang
Article
Radiology, Nuclear Medicine & Medical Imaging
Bincy Anu John, Tingting Xu, Steven Ripp, Hwa-Chain Robert Wang
MOLECULAR IMAGING AND BIOLOGY
(2017)
Article
Virology
Wen Meng, Shi-Chong Han, Cui-Cui Li, Hui-Jun Dong, Jian-Yu Chang, Hwa-Chain Robert Wang, Xiao-Jia Wang
Article
Environmental Sciences
Abdul-Fattah Salah Fararjeh, Shih-Hsin Tu, Li-Ching Chen, Tzu-Chun Cheng, Yun-Ru Liu, Hang-Lung Chang, Hui-Wen Chang, Chi-Cheng Huang, Hwa-Chain Robert Wang, Wendy W. Hwang-Verslues, Chih-Hsiung Wu, Yuan-Soon Ho
ENVIRONMENTAL TOXICOLOGY
(2019)
Article
Biochemistry & Molecular Biology
Shambhunath Choudhary, Shilpa Sood, Hwa-Chain Robert Wang
MOLECULAR CARCINOGENESIS
(2014)
Article
Multidisciplinary Sciences
Lenora Ann Pluchino, Hwa-Chain Robert Wang
Review
Microbiology
Wen Meng, Xiao-Jia Wang, Hwa-Chain Robert Wang
CRITICAL REVIEWS IN MICROBIOLOGY
(2019)
Article
Oncology
Yan-Hong Yong, Ping Wang, Ru-Min Jia, Ravi Gooneratne, Hwa-Chain Robert Wang, Ming Liao, Xiang-Hong Ju
INTERNATIONAL JOURNAL OF HYPERTHERMIA
(2019)
Review
Pharmacology & Pharmacy
Cui-Cui Li, Xiao-Jia Wang, Hwa-Chain Robert Wang
DRUG DISCOVERY TODAY
(2019)
Article
Oncology
Pawat Pattarawat, Shelby Wallace, Bianca Pfisterer, Agricola Odoi, Hwa-Chain Robert Wang
CANCER CHEMOTHERAPY AND PHARMACOLOGY
(2020)
Article
Oncology
Pawat Pattarawat, Hong Tian, Shelby Wallace, Hu Yanchun, Robert Donnell, Wang Tzu-Hao, Tsai Chia-Lung, Wang Jinquan, Hwa-Chain Robert Wang
BRITISH JOURNAL OF CANCER
(2020)
Article
Oncology
Pawat Pattarawat, Jessica T. Hunt, Jacob Poloway, Collin J. Archibald, Hwa-Chain Robert Wang
Summary: The study demonstrated the efficacy of gemcitabine plus romidepsin + cisplatin regimen in controlling TNBC tumor development, recurrence, and metastasis in animal models, showing significant inhibition effects in reducing tumor growth and metastatic nodules.
CANCER CHEMOTHERAPY AND PHARMACOLOGY
(2021)
Meeting Abstract
Oncology
Hwa-Chain Robert Wang, Lenora Ann Pluchino
ANTICANCER RESEARCH
(2014)
Review
Oncology
Xinru Zhou, Yin Jia, Chuanbin Mao, Shanrong Liu
Summary: Small extracellular vesicles (sEVs), such as exosomes, have emerged as crucial targets for liquid biopsy and promising drug delivery vehicles in tumor progression. They can serve as biomarkers for tumor diagnosis and as drug carriers for cancer treatment.
Article
Oncology
Ruochan Chen, Ju Zhu, Xiao Zhong, Jie Li, Rui Kang, Daolin Tang
Summary: The interplay between autophagy and apoptosis plays a crucial role in tumorigenesis and cancer therapy, with HMGB1 serving as a key regulator in these processes.
Article
Oncology
Zongfu Pan, Xixuan Lu, Tong Xu, Jinming Chen, Lisha Bao, Ying Li, Yingying Gong, Yulu Che, Xiaozhou Zou, Zhuo Tan, Ping Huang, Minghua Ge
Summary: This study uncovered the emerging role of HN1 in promoting dedifferentiation of anaplastic thyroid cancer (ATC) cells. HN1 negatively regulated the thyroid differentiation markers and had an inhibitory effect on the transcriptional activation of CTCF, thereby influencing the chromatin accessibility of thyroid differentiation genes.
Article
Oncology
Yi Qin, Shengjun Xiong, Jun Ren, Gautam Sethi
Summary: Autophagy plays an important regulatory role in glioblastoma, and its dysregulation can lead to drug resistance and radioresistance. It also affects stem cell characteristics, overall growth, and metastasis. Therefore, autophagy is a promising target for glioblastoma therapy.
Article
Oncology
Katsuya Nagaoka, Xuewei Bai, Dan Liu, Kevin Cao, Joud Mulla, Chengcheng Ji, Hongze Chen, Muhammad Azhar Nisar, Amalia Bay, William Mueller, Grace Hildebrand, Jin-Song Gao, Shaolei Lu, Hiroko Setoyama, Yasuhito Tanaka, Jack R. Wands, Chiung-Kuei Huang
Summary: This study found that serum 2-OG levels in cholangiocarcinoma patients are associated with the effectiveness of chemotherapy. Patients with progressive disease showed significantly higher levels of serum 2-OG compared to stable disease and partial response patients. The study also revealed that overexpression of ASPH mimics the effects of 2-OG, and knockdown of ASPH improves chemotherapy. Targeting ASPH enhances the effects of chemotherapy by modulating ATM and ATR, two key regulators of DDRs.